MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$29,835K
Exchange differences on
translation of foreign...
$5,679K
Net loss
-$35,514K
US
$256,998K
Europe
$131,422K
International
$11,596K
Net loss before
income taxes
-$19,100K
Income tax (expense)
benefit
$16,414K
Other income
(expense), net
$19,728K
Interest income
$16,476K
Sale Of Therapies
$400,016K
Foreign currency gain
(loss)
$2,215K
Loss from operations
-$45,353K
Total revenue
$400,016K
Interest expense
$12,166K
Research and development
expense
$274,869K
Selling, general and
administrative expense
$165,413K
Cost of revenue from
sale of therapies
$5,087K
Back
Back
Income Statement
source: myfinsight.com
Immunocore Holdings plc (IMCR)
Immunocore Holdings plc (IMCR)